BCL6 and hepatocellular carcinoma: WTAP, a vital component of the m6A writer, has been shown to contribute to the progression of various cancers, stabilizing the expression of the transcriptional repressor BCL6 in diffuse large B-cell lymphoma50, promoting the progression of hepatocellular carcinoma via ETS1 silence51, influencing tumor-associated T lymphocyte infiltration in gastric cancer52, and predicting poor prognosis in acute myeloid leukemia by regulating MYC mRNA53.